Fluoxazolevir inhibits hepatitis C virus infection in humanized chimeric mice by blocking viral membrane fusion

Fluoxazolevir is an aryloxazole-based entry inhibitor of hepatitis C virus (HCV). We show that fluoxazolevir inhibits fusion of HCV with hepatic cells by binding HCV envelope protein 1 (E1) to prevent fusion. 9 of 10 fluoxazolevir-resistance-associated substitutions are in the E1 protein and 4 are i...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Nat Microbiol
Autors principals: Ma, Christopher D., Imamura, Michio, Talley, Daniel C., Rolt, Adam, Xu, Xin, Wang, Amy Q., Le, Derek, Uchida, Takuro, Osawa, Mitsutaka, Teraoka, Yuji, Li, Kelin, Hu, Xin, Park, Seung Bum, Chalasani, Nishanth, Irvin, Parker H., Dulcey, Andres E., Southall, Noel, Marugan, Juan J., Hu, Zongyi, Chayama, Kazuaki, Frankowski, Kevin J., Liang, T. Jake
Format: Artigo
Idioma:Inglês
Publicat: 2020
Matèries:
Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC7677215/
https://ncbi.nlm.nih.gov/pubmed/32868923
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41564-020-0781-2
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars